Authors


Umida Nasritdinova, PharmD Candidate

Latest:

Vaginal Microbiome Transplantation Effective in Intractable Bacterial Vaginosis

A recent study reported the benefit of vaginal microbiome transplantation for the treatment of recurrent bacterial vaginosis.


NIHAAL KARNIK, MD

Latest:

Salt, Ticks, and Lyme: A Case of Lyme Neuroborreliosis Presenting as SIADH

This case report is the fourth documented case of Lyme-induced syndrome of inappro­priate secretion of antidiuretic hormone (SIADH).


Emily Heil, PharmD, BCPS-AQ ID, Monica Mahoney, PharmD, BCPS-AQ ID

Latest:

The Ultimate Infectious Disease Pharmacist Holiday Wish List

In case you were wondering what to get the infectious disease (ID) pharmacist in your life for the upcoming holidays.


Thelma King Thiel, RN, BA

Latest:

With October Being Liver Awareness Month, an Opportunity to Acknowledge This Essential Organ

It is important to recognize this organ that has multiple life-enhancing functions.


LAURI HICKS, DO

Latest:

Managing Reluctant Antibiotic Stewards: Advice From an ID Physician and an ID Pharmacist

Although challenging, it is not impossible to change some outlier behaviors.



MARY BETTE FORTE, MSN-ED, RN

Latest:

Actively Involving Nurses in Antibiotic Stewardship

Staff nurses are underused but potentially valuable contributors to antibiotic stewardship.


Kevin Kunzmann

Latest:

What Can the United States Learn from India's Hepatitis C Eradication Model?

Madhumita Premkumar, MD, discusses a nationwide, cost-efficient eradication strategy she believes could benefit Americans' efforts to curb HCV.


Jason Harris

Latest:

Investigators Find Large Survival Disparities Among Patients with HPV-Associated Cancers

A recent study finds that younger patients, women, and white individuals infected with HPV-associated cancers have superior survival at 5 years.




THOMAS P. LODISE, PHARMD, PHD*

Latest:

Two More Agents Bolster the Arsenal Against Gram-Negative Resistance

As the antibiotic pipeline produces new therapies, clinicians must understand each agent’s specific role in manage­ment of patients infected by multidrug-resistant pathogens.


Maria Heaney, PharmD

Latest:

A Case of Candida Albicans Ventriculitis Secondary to E Coli Ventriculoperitoneal Shunt Infection

Rare cases of health care–associated meningitis and ventriculitis in adults caused by Candida species are associated with recent bacterial meningitis and broad-spectrum antibiotic use.


SARA ALOSAIMY, PHARMD, BCPS

Latest:

Eravacycline: The IGNITE Growth of the Tetracyclines

The synthetic novel tetracycline offers a new option for complicated intra-abdominal infections.


Christian Y. Cho, PharmD

Latest:

Duration of Antibiotic Therapy for Uncomplicated Gram-Negative Bacteremia: Seven Is the New Fourteen

The treatment duration for uncomplicated gram-negative bloodstream infections (BSIs) has traditionally ranged from 7 to 14 days. However, recent retrospective studies and meta-analyses have observed no differences in clinical outcomes in patients treated with shorter courses compared with prolonged courses, especially with urinary sources of infection.


CEO

Latest:

Reassessing Practices Is Critical During an Infectious Disease Outbreak

The constant reassessment of business practices is necessary to ensure that practitioners are not wasting valuable time, resources, and effort on activities that are not producing the desired results.


Kylie Pritchard, PharmD, BCPS-AQ ID

Latest:

Lessons From the MERINO Trial

Is the use of piperacillin/tazobactam for bacteremia caused by ceftriaxone-nonsusceptible Escherichia coli and Klebsiella pneumoniae an obsolete practice?


Alvaro Toledo, PhD

Latest:

Tick, Tick, Tick: Vector-Borne Diseases Ramp Up

Infections transmitted by these bloodsucking species are on the rise worldwide.


Daniel Holland, PharmD

Latest:

Assessing Statin Use in HIV-Positive Patients Taking Protease Inhibitors

A recent study takes a closer look at statin use in HIV-positive patients who are taking protease inhibitors.



Konrad Reinhart, MD

Latest:

Sepsis and Antimicrobial Resistance Awareness Gain Ground, But Action Must Continue

As antimicrobial therapies become less effective, more people are at risk for infections that can progress to sepsis.


Hermione Hurley, MD, MBChB

Latest:

With the Opioid Epidemic, Communities See Dramatic Increases in Infectious Diseases

Rising incidence of viral and bacterial infections has accompanied the opioid crisis, but it also presents new opportunities for multidisciplinary treatment and preventive care.


Lindsay Courtney, PharmD

Latest:

Two Allergies or Cross-Reactive?

The story of penicillin and cefazolin.


Julie Ann Justo, PharmD, MS

Latest:

“Triple Therapy” Facing Triple Threat

Clinicians provide an overview of intraamniotic infections and offer treatment strategies for these challenging infections.


Jamie Wagner, PharmD, BCPS

Latest:

A Long-Term Care Antimicrobial Stewardship Certificate Program for Pharmacists: Filling an Unmet Need

This training will empower pharmacists practicing in LTC facilities to develop antimicrobial stewardship programs, improve patient outcomes related to infectious diseases, and facilitate compliance with CMS requirements.


Daniel Anderson, PharmD

Latest:

Intravenous Fosfomycin for Systemic Multidrug-Resistant Infections

Intravenous (IV) fosfomycin offers a novel therapeutic option in the treatment of systemic multi-drug resistant (MDR) infections. Unanswered questions remain regarding its efficacy and specific role in our therapeutic arsenal.


Thomas M File, Jr. MD, MSc, MACP, FIDSA, FCCP

Latest:

Thomas M. File, Jr., MD: COVID-19 Requires a Unified Approach

In addition to providing important expertise into the management of this infection, our role in educating the public—in many cases providing an important perspective when fears tend to run high—is also essential.


NATALIE DICENZO

Latest:

Never Ignore a New Rash in a Patient With AIDS

A case of Kaposi sarcoma with immune reconstitution inflammatory syndrome.



Kirk E. Hevener, PharmD, PhD

Latest:

Bioaccumulation of Drugs by Human Gut Bacteria Can Affect Drug Availability

A new study demonstrated that gut organisms can alter drug availability by biotransformation on a significantly broader scale than previously expected.

© 2025 MJH Life Sciences

All rights reserved.